<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>9542247</identifier>
<setSpec>0303-8874</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Chocarro Martínez, A</dc:author>
<dc:author>Pardal Refoyo, J L</dc:author>
<dc:author>Parra Pérez, C</dc:author>
<dc:author>Brezmes Valdivieso, M F</dc:author>
<dc:description xml:lang="en">The rhinocerebral mucormycosis is the more common form produced by Rhizopus, a genus of fungi. It's a serious infective disease with high mortality, that needs a precocious medical treatment. Amphotericin B is the choice medical treatment, but liposomal amphotericine B in recent years is a better drug, due to minor renal toxicity and greater tisular diffusion. Even can not to treat all affected areas it's necessary an extensive surgical treatment according to individual characteristics and disease evolution. A 56-year-old man with rhinocerebral mucormycosis, caused by Rhizopus, who was treated with liposomal-amphotericin B and extensive rhino-orbital surgery is presented.</dc:description>
<dc:type>Case Reports</dc:type>
<dc:language>es</dc:language>
<dc:date>1998 </dc:date>
<dc:title xml:lang="es">Revisión del tratamiento en la mucormicosis rinocerebral.</dc:title>
<dc:title xml:lang="en">[Treatment review in rhinocerebral mucormycosis].</dc:title>
<dc:publisher>Anales otorrinolaringologicos ibero-americanos</dc:publisher>
</metadata>
</record>
</pubmed-document>
